top of page
  • Ann Tucker

FDA Overdose Prevention Framework Supports HHS, ONDCP Strategies

Recently released, the FDA Overdose Prevention Framework identifies four priorities designed to complement the HHS Overdose Prevention Strategy and the ONDCP National Drug Control Strategy: (1) Supporting primary prevention by eliminating unnecessary initial prescription drug exposure and inappropriate prolonged prescribing; (2) Encouraging harm reduction through innovation and education; (3) Advancing development of evidence-based treatments for substance use disorders; and (4) Protecting the public from unapproved, diverted, or counterfeit drugs presenting overdose risks.

2 views0 comments

Recent Posts

See All

SAMHSA (11/10) –– The Substance Abuse and Mental Health Services Administration is pleased to announce the release of the agency’s Interim Strategic Plan (ISP), which presents a new mission and vision

The White House budget office is reviewing a draft SAMHSA rule that would make permanent the COVID-19 methadone take-home waiver and define which patients with OUD are considered “stable” enough to re

bottom of page